Blog
NVO's CagriSema Outshines Semaglutide in Phase III Diabetes Study
Novo Nordisk NVO announced positive top-line data from a late-stage study in its global REIMAGINE clinical study program for a next-generation pipeline candidate, CagriSema, for treating adults with
This Week's 5 Must-See Earnings Charts
It is another busy week for earnings as hundreds of companies are expected to report, including many S&P 500 companies. Two Magnificent 7 stocks are also going to report earnings this week: Amazon
Microchip to Report Q3 Earnings: What's in Store for the Stock?
Microchip Technology MCHP is set to report third-quarter fiscal 2026 results on Feb. 5, 2026.
Microchip expects net sales to be in the range of $1.109-$1.149 billion for the third quarter of fiscal
3 School Stocks Leveraging AI & Healthcare Demand Amid Headwinds
What's in the Cards for Cboe Global This Earnings Season?
Cboe Global Markets, Inc. CBOE is expected to register an improvement in its top and bottom lines when it reports fourth-quarter 2025 results on Feb. 6, before the opening bell.The Zacks Consensus
KKR & Co. to Post Q4 Earnings: Here's What to Expect From the Stock
KKR & Co. Inc. KKR is slated to report fourth-quarter 2025 results on Feb. 5, 2026, before the opening bell. Its earnings in the quarter are expected to have decreased year over year, while revenues
Here's What Key Metrics Tell Us About Heartland Express (HTLD) Q4 Earnings
Heartland Express (HTLD) reported $179.36 million in revenue for the quarter ended December 2025, representing a year-over-year decline of 26.1%. EPS of -$0.06 for the same period compares to -$0.02
Compared to Estimates, Rithm (RITM) Q4 Earnings: A Look at Key Metrics
Rithm (RITM) reported $1.29 billion in revenue for the quarter ended December 2025, representing a year-over-year decline of 38.6%. EPS of $0.74 for the same period compares to $0.60 a year ago.
The
Natera Files Signatera CDx PMA With FDA for Bladder Cancer MRD Test
Natera NTRA recently announced the submission of a premarket approval (PMA) application to the FDA for its Signatera CDx test, a personalized molecular residual disease (MRD) assay for patients with
Q4 Earnings, JOLTS & a Changing of the Disney Guard
Tuesday, February 3rd, 2026Kicking off another day of trading, the Dow is flat but other indexes are up: the S&P 500 +0.23%, the Nasdaq +0.51% and the small-cap Russell 2000 +0.32%. The rebound off
BRBS Stock Gains Post Q4 Earnings on Cost Cuts, Consent Order Exit
Shares of Blue Ridge Bankshares, Inc. BRBS have gained 0.23% since reporting results for the quarter ended Dec. 31, 2025, outperforming the S&P 500 Index, which rose 0.19% over the same period
Willis Towers Q4 Earnings & Revenues Beat Estimates on Lower Expenses
Willis Towers Watson Public Limited Company WTW delivered fourth-quarter 2025 adjusted earnings of $8.12 per share, which beat the Zacks Consensus Estimate by 2.5%. The bottom line increased 2% year
Canadian Pacific Q4 Earnings & Revenues Miss Estimates, Improve Y/Y
Canadian Pacific Kansas City (CP) reported unimpressive fourth-quarter 2025 results, wherein both earnings and revenues missed the Zacks Consensus Estimate.
Quarterly earnings (excluding 9 cents
DaVita Stock Up Following Q4 Earnings & Revenue Beat, Margins Expand
DaVita Inc. DVA delivered adjusted earnings per share (EPS) from continuing operations of $3.40 in the fourth quarter of 2025, up 51.8% year over year. The figure surpassed the Zacks Consensus
HAIN to Divest North American Snacks Business to Focus on Core Areas
The Hain Celestial Group, Inc. HAIN has taken a decisive step to refine its business strategy by entering into a definitive agreement to sell its North American Snacks business, including the Garden
Should You Buy, Sell, or Hold Reddit Stock Before Q4 Earnings Release?
Reddit RDDT is set to release its fourth-quarter 2025 results on Feb. 5, 2026.For the fourth quarter of 2025, RDDT expects revenues between $655 million and $665 million, representing 53% to 55%
Spire's Q1 Earnings Higher Than Estimates, Revenues Rise Y/Y
Spire Inc. SR reported first-quarter fiscal 2026 adjusted earnings of $1.77 per share, which beat the Zacks Consensus Estimate of $1.62 by 9.3%. The company’s bottom line also rose 32.1% from $1.34
Heartland Express (HTLD) Reports Q4 Loss, Misses Revenue Estimates
Heartland Express (HTLD) came out with a quarterly loss of $0.06 per share versus the Zacks Consensus Estimate of a loss of $0.07. This compares to a loss of $0.02 per share a year ago. These
Best Momentum Stocks to Buy for February 3rd
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, February 3
CEMEX, S.A.B. de C.V. CX: This cement and construction materials company has a








